Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare(Healthcare & Medicine)
Filter PR by
  
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
 
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
Protein-based therapeutics prevent protein aggregation associated with Alzheimer’s and other neurodegenerative diseases
 
Fast facts
● Alzheimer’s disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer’s disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain’s neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton’s lab at NYU New York and Professor Astrid Gräslund’s lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington’s, Parkinson’s, and Alzheimer’s, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer’s disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer’s disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”


Posted by : Dubai PR Network Editorial Team
Viewed 10864 times
PR Category : Healthcare & Medicine
Posted on : Saturday, February 8, 2020  9:03:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Aster DM Healthcare Wins 6 Awards at AHPI Awards 2020
Next Story : Aster Hospitals Dubai achieves diamond level status from Acc...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Parmigiani Fleurier Salutes the Spirit of Valentine's Day with Tonda Reine de Mai [8208-Views]
AIGNER Haute Couture Jewellery Collection CHIARA [5355-Views]
Add Extra Sparkle to Your Holidays With Make Up for Ever's 2020 Holiday Collection [5342-Views]
Discover the Ingredients [3760-Views]
Liverpool Legend Ian Rush visits Dubai Sports Council, Discusses Starting Projects in Duba... [3510-Views]
Samsung Introduces Latest Innovations for a Better Normal at CES 2021 [3337-Views]
A Warm Summer Rain in Winter: The New Head Shower GROHE Tempesta 250 [3206-Views]
Canon Recognizes 3 Leading Photographers from the UAE, KSA & Jordan for their Ambassador P... [3173-Views]
Schneider Electric Unveils New Sustainable Energy Products at CES 2021 [3100-Views]
The University of Queensland wins Ericsson Innovation Awards 2020 [3034-Views]
Roma Proves the Pace of the Hunter to Go 5th Overall, as Loeb Suffers Suspension Damage [2989-Views]
The Ideal 2021 Shoedrobe - Steve Madden [2964-Views]
Moonwatch now Master Chronometer Certified [2944-Views]
What's your Colour Code? [2780-Views]
Bridgestone To Debut Virtual City of the Future, Showcase Mobility Solutions at CES 2021 [2685-Views]
Dubai Customs: Exceptional Achievements in 2020 Despite Coronavirus Challenges [2608-Views]
World Gold Council ETF 2020 Report and Gold Outlook 2021 [2398-Views]
INFINITI of Arabian Automobiles Launches Limited Time Offer on the QX80 2021 [2337-Views]
Western Digital Delivers Unmatched Line Up of High-capacity Portable SSDS Across Its Renow... [2173-Views]
Abu Dhabi Motors Gears Up for 2021 [2165-Views]
Samsung Electronics Debuts 2021 Neo QLED, MICRO LED and Lifestyle TV Lines, Highlighting C... [1993-Views]
Omega Dubai Desert Classic [1960-Views]
The Most Inclusive Range of Primers to Offer 24hr Correction for Any Skin Type, Any Skin T... [1902-Views]
Lenovo Yoga Slim 7i Pro Laptop Now Features OLED Display [1902-Views]
IATA Welcomes the Resumption of Air Connectivity between Key Nations in the Middle East [1861-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories